Global Transplantation Market to Reach $22.7 Billion by 2030
The global market for Transplantation estimated at US$13 Billion in the year 2022, is projected to reach a revised size of US$22.7 Billion by 2030, growing at a CAGR of 7.2% over the analysis period 2022-2030. Organ Transplantation, one of the segments analyzed in the report, is projected to record 7% CAGR and reach US$8.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Tissue Transplantation segment is readjusted to a revised 7.3% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 11.8% CAGR
The Transplantation market in the U.S. is estimated at US$3.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.6 Billion by the year 2030 trailing a CAGR of 11.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.Select Competitors (Total 118 Featured) -
- Abbott Laboratories, Inc.
- Acelity LP, Inc.
- Avioq, Inc.
- AxoGen, Inc.
- BD Biosciences
- BioLife Solutions Inc.
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- Carmat SA
- Chronix Biomedical
- Dr. Franz Kohler Chemie GmbH
- F. Hoffmann-La Roche AG
- GenDx
- Histogenics Corporation
- Illumina, Inc.
- Luminex Corporation
- Medipex Limited
- Miromatrix Medical Inc.
- Nano Dimension Ltd.
- Organovo Holdings, Inc.
- Ortho Clinical Diagnostics
- Oxford Immunotec Global PLC
- Pacific Biosciences of California, Inc.
- Pandorum Technologies Pvt. Ltd.
- Qiagen NV
- Siemens Healthineers
- SynCardia
- Thermo Fisher Scientific, Inc.
- Transplant Biomedicals S.L.
- XVIVO Perfusion AB
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIV. COMPETITION
1. MARKET OVERVIEW
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories, Inc.
- Acelity LP, Inc.
- Avioq, Inc.
- AxoGen, Inc.
- BD Biosciences
- BioLife Solutions Inc.
- Bio-Rad Laboratories, Inc.
- CareDx, Inc.
- Carmat SA
- Chronix Biomedical
- Dr. Franz Kohler Chemie GmbH
- F. Hoffmann-La Roche AG
- GenDx
- Histogenics Corporation
- Illumina, Inc.
- Luminex Corporation
- Medipex Limited
- Miromatrix Medical Inc.
- Nano Dimension Ltd.
- Organovo Holdings, Inc.
- Ortho Clinical Diagnostics
- Oxford Immunotec Global PLC
- Pacific Biosciences of California, Inc.
- Pandorum Technologies Pvt. Ltd.
- Qiagen NV
- Siemens Healthineers
- SynCardia
- Thermo Fisher Scientific, Inc.
- Transplant Biomedicals S.L.
- XVIVO Perfusion AB
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 232 |
| Published | April 2024 |
| Forecast Period | 2022 - 2030 |
| Estimated Market Value ( USD | $ 13 Billion |
| Forecasted Market Value ( USD | $ 22.7 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
